NCT03834129View on ClinicalTrials.gov

Dexmedetomidine Intra Venous Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

January 11, 2020

Study Completion Date

January 11, 2020

Conditions
Primary Total Knee Arthroplasty
Interventions
DRUG

Dexmedetomidine

Two administrations, before anesthesia and during surgery, by intravenous infusion of dexmedetomidine 1 μg/kg in 250 ml of physiological serum for 30 minutes

DRUG

sodium chloride 0.9%

Two administrations, before anesthesia and during surgery, by intravenous infusion of 250 ml of physiological serum for 30 minutes

Trial Locations (1)

31036

Clinique Médipôle Garonne, Toulouse

All Listed Sponsors
lead

CMC Ambroise Paré

OTHER

NCT03834129 - Dexmedetomidine Intra Venous Arthroplasty | Biotech Hunter | Biotech Hunter